InsidersTradesSigma
Browse the full record of transactions filed by FRATTAROLI JOSEPH, Chief Financial Officer. Officer active across 1 companies, notably Inhibikase Therapeutics, Inc.. Aggregated, 1 reports have been logged. Total volume traded: €2k. The latest transaction was disclosed on 19 May 2022 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
1 of 1 declaration
Frattaroli Joseph is the Chief Financial Officer at Inhibikase Therapeutics, Inc. He is responsible for the financial management of the company, including financial planning and analysis. His expertise is essential to support the company's growth and profitability.